Cargando…
Clinical Manifestations and Diagnosis of Nonalcoholic Fatty Liver Disease
BACKGROUND & OBJECTIVE: Nonalcoholic fatty liver diseases (NAFLD) is the major cause of hepatocellular carcinoma and increases the risk of mortality. Understanding the trends of its clinical and biochemical changes is essential to identify patients with NAFLD that are at the greatest risk of non...
Autores principales: | Khoonsari, Mahmoodreza, Mohammad Hosseini Azar, Mohammadreza, Ghavam, Ramak, Hatami, Khadijeh, Asobar, Mosa, Gholami, Ali, Rajabi, Abdolhalim, Safarnezhad Tameshkel, Fahimeh, Amirkalali, Bahare, Sohrabi, Masoudreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society of Pathology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831064/ https://www.ncbi.nlm.nih.gov/pubmed/29515630 |
Ejemplares similares
-
Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients?
por: Sohrabi, Masoudreza, et al.
Publicado: (2021) -
Melatonin Levels in Patients with Nonalcoholic Fatty Liver Disease Compared with Healthy Individuals according to Fibrosis Level
por: Sohrabi, Masoudreza, et al.
Publicado: (2021) -
Effect of Baseline Resistance-Associated Substitutions on Thalassemia Patients with Chronic HCV Infection: A Two-Year Follow-Up
por: Safarnezhad Tameshkel, Fahimeh, et al.
Publicado: (2021) -
Household Food Insecurity and Associated Factors among Iranian Patients with Esophageal and Gastric Cancers
por: Sohrabi, Masoudreza, et al.
Publicado: (2023) -
Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial
por: Attaran, Fereshte, et al.
Publicado: (2023)